Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-025372
Filing Date
2007-02-09
Accepted
2007-02-09 13:21:54
Documents
7
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 653129
2 SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1705
3 CONSENT OF SWENSON ADVISORS, LLP dex231.htm EX-23.1 1695
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 9908
5 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 10073
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 5189
7 GRAPHIC g55831g93e89.jpg GRAPHIC 21673
  Complete submission text file 0001193125-07-025372.txt   713238
Mailing Address 888 PROSPECT STREET SUITE 320 LA JOLLA CA 92037
Business Address 888 PROSPECT STREET SUITE 320 LA JOLLA CA 92037 8586460789
AKESIS PHARMACEUTICALS, INC. (Filer) CIK: 0001042420 (see all company filings)

EIN.: 841409219 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27409 | Film No.: 07596804
SIC: 7389 Services-Business Services, NEC